Research Supports Theory of Nonceliac Gluten Sensitivity

This article originally appeared here.
Share this content:
Research Supports Theory of Nonceliac Gluten Sensitivity
Research Supports Theory of Nonceliac Gluten Sensitivity

FRIDAY, Oct. 2, 2015 (HealthDay News) -- For patients with suspected nonceliac gluten sensitivity (NCGS), overall symptom severity increases with intake of small amounts of gluten, according to a study published in the September issue of Clinical Gastroenterology and Hepatology.

Antonio Di Sabatino, M.D., from the University of Pavia in Italy, and colleagues conducted a randomized trial to determine the effects of administration of low doses of gluten to subjects with suspected NCGS. Sixty-one adults without celiac disease or a wheat allergy who believed ingestion of foods containing gluten were the cause of their intestinal and extraintestinal symptoms were enrolled. Participants were randomized to receive 4.375 g/day of gluten or control (rice starch) for one week. Participants crossed over to the other group after a one-week gluten-free diet. Fifty-nine patients completed the trial.

The researchers found that, compared with placebo, intake of gluten significantly increased overall symptoms (P = 0.034). When patients received gluten versus placebo they had significantly more severe intestinal symptoms of abdominal bloating and pain (P = 0.040 and 0.047, respectively) and extraintestinal symptoms of foggy mind, depression, and aphthous stomatitis (P = 0.019, 0.020, and 0.025, respectively).

"In a cross-over trial of subjects with suspected NCGS, the severity of overall symptoms increased significantly during one week of intake of small amounts of gluten, compared with placebo," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »